Lumibird
13.53
21-May-25 10:02:24
15 minutes delayed
Stocks
+1.63
+13.66%
Today's range
12.55 - 13.53
ISIN
FR0000038242
Source
Cboe
-
LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR SKYRANGER 30
12 May 2025 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: REVENUE GROWTH OF+ 12.4% IN THE 1st QUARTER
28 Apr 2025 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2025
21 Mar 2025 12:45:00 By Nasdaq GlobeNewswire
-
11 Mar 2025 12:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: 2024 SALES AT €207.1M (+1.7% -REPORTED)
27 Jan 2025 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA
24 Jan 2025 11:45:00 By Nasdaq GlobeNewswire
-
Lumibird : nombre de droits de vote et d'actions au 30 novembre 2024
09 Dec 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION
27 Nov 2024 02:00:00 By Nasdaq GlobeNewswire
-
21 Oct 2024 11:55:15 By Nasdaq GlobeNewswire
-
LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M
15 Oct 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: FIRST-HALF RESULTS FOR 2024 UP IN THE MEDICAL DIVISION, LOWER IN THE PHOTONICS DIVISION
24 Sep 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD RECEIVES NEW ORDERS FROM THALES
24 Jul 2024 11:35:00 By Nasdaq GlobeNewswire
-
22 Jul 2024 11:50:17 By Nasdaq GlobeNewswire
-
LUMIBIRD PRESENTS ITS NEW STRATEGIC PLAN
22 May 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE
03 May 2024 01:30:00 By Nasdaq GlobeNewswire
-
05 Apr 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2024
25 Mar 2024 12:45:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 12:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR CV90
29 Feb 2024 11:45:00 By Nasdaq GlobeNewswire
-
LUMIBIRD: 2023 REVENUES AT €203.6M
29 Jan 2024 11:46:50 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >